Sort
25,944 grants matching “neurodegeneration”
Functions of alpha-Synuclein in Neurotransmitter Release
$299,250Jianhua Xu · Augusta University · R01 · FY2018 · NS
Perceptual mechanisms underlying reading difficulties in glaucoma
$299,250Miyoung Kwon · Northeastern University · R01 · FY2020 · EY
Functions of alpha-Synuclein in Neurotransmitter Release
$299,250Jianhua Xu · Augusta University · R01 · FY2016 · NS
Regulation of cell death and disease by a novel membrane protein MADMAN.
$299,167Zhigao Wang · University Of South Florida · R01 · FY2022 · GM
Screen For Inhibitors of Parkin E3 Autoubiquition
$299,135Progenra, Inc. · R43 · FY2004 · NS
Identification of novel Parkinsonian genes by wholegenome
$299,122Rosa Rademakers · Mayo Clinic Jacksonville · P50 · FY2015 · NS
GENETIC DISSECTION OF A NEURODEGENERATION PATHWAY
$299,114University Of California San Diego · R01 · FY2000 · MH
Lipid droplet regulation and proteome dynamics
$299,110James A Olzmann · University Of California Berkeley · R01 · FY2024 · DK
Mechanisms for chromatin modification during transcription elongation
$299,079Bing Li · Ut Southwestern Medical Center · R01 · FY2014 · GM
Dual function ubiquitin-like proteins in post-translational regulation and sulfur mobilization
$299,047Julie A Maupin-Furlow · University Of Florida · R01 · FY2023 · GM
Mechanisms for chromatin modification during transcription elongation
$299,001Bing Li · Ut Southwestern Medical Center · R01 · FY2012 · GM
VP22 AND TAT mediated gene therapy for the CNS
$299,000University Of Utah · R01 · FY2004 · EY
VP22 AND TAT mediated gene therapy for the CNS
$299,000University Of Utah · R01 · FY2005 · EY
Structural and Functional CNS Changes in Myotonic Dystrophy Types 1 and 2
$299,000John W Day · Stanford University · R01 · FY2011 · NS
Role of sumoylation during stress signaling responses
$298,980Richard George Gardner · University Of Washington · R01 · FY2017 · GM
Synaptic toxicity of Huntington disease protein
$298,956Xiao-Jiang Li · Emory University · R01 · FY2013 · AG
NEUROPATHOLOGY AND NEUROSCIENCES
$298,947Eliezer Masliah · Scripps Research Institute, The · P01 · FY2010 · AG
Amadorins as a Novel Oral Therapeutic for Diabetic Retinopathy
$298,940Raja G Khalifah · Praetego, Inc. · R41 · FY2023 · EY
Project 3: Assembly and structures of Abeta peptides.
$298,852William F Degrado · University Of California, San Francisco · P01 · FY2015 · AG
RNA trafficking in mitochondria
$298,835Carla M. Koehler · University Of California Los Angeles · R01 · FY2010 · GM
Development of AAV-AXN-007 gene therapy to treat glaucoma.
$298,819Shane Hegarty · Axonis Therapeutics, Inc. · R43 · FY2022 · EY
MELATONIN- A NEW ANTI-AMYLOIDOGENIC &ANTIOXIDANT AGENT
$298,797University Of South Alabama · R01 · FY2002 · AG
Role of Phospholipid Remodeling in Secretion and Golgi Function in Mammalian Cell
$298,723William J Brown · Cornell University · R01 · FY2014 · GM
Elucidating the cellular mechanisms of prion propagation and clearance for devisi
$298,698Donald L. Jarvis · University Of Wyoming · R01 · FY2013 · NS
AN ENDOPLASMIC RETICULUM CALCIUM STABILIZER FOR THE TREATMENT OF WOLFRAM SYNDROME
$298,696Fumihiko Urano · Washington University · UH2 · FY2018 · TR